Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study
- Resource Type
- Article
- Source
- In
Digestive and Liver Disease January 2024 56(1):198-205 - Subject
- Language
- ISSN
- 1590-8658